S&P 500

5.460,48

-0,41%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Scinai Immunotherapeutics Ltd (SCNI)
Scinai Immunotherapeutics Ltd (SCNI) Notícias

SCNI

Scinai Immunotherapeutics (SCNI)

Scinai Immunotherapeutics Ltd

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SCNI

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
14/06/2024	08:26	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
13/06/2024	08:00	PR Newswire (US)	Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
07/06/2024	08:00	PR Newswire (US)	Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
24/05/2024	17:01	PR Newswire (US)	Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
16/05/2024	14:49	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
15/05/2024	17:01	PR Newswire (US)	Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
06/05/2024	10:21	PR Newswire (US)	Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
10/04/2024	08:00	PR Newswire (US)	Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
08/04/2024	18:15	AllPennyStocks.com	Biotech Rips Following Five-Year Master Service Agreement Release	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
08/04/2024	08:00	PR Newswire (US)	Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
12/03/2024	09:00	PR Newswire (US)	Scinai leadership to attend BIO-Europe Spring 2024	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
29/02/2024	10:45	PR Newswire (US)	Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
13/02/2024	09:00	PR Newswire (US)	Scinai Welcomes Liat Halpert as Head of Business Development and Sales	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
30/01/2024	18:19	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
25/01/2024	12:26	PR Newswire (US)	Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
24/01/2024	16:33	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
12/01/2024	09:32	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
04/01/2024	18:01	PR Newswire (US)	Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
04/01/2024	08:15	PR Newswire (US)	Scinai Immunotherapeutics CEO Issues Letter to Shareholders	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
29/12/2023	11:21	PR Newswire (US)	Scinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
27/12/2023	09:15	PR Newswire (US)	Scinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar on January 9	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
27/12/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
22/12/2023	11:11	Edgar (US Regulatory)	Form F-1/A - Registration statement for certain foreign private issuers: [Amend]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
12/12/2023	09:26	PR Newswire (US)	Scinai Announces Promising Results in a Psoriatic Human Skin Model	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
11/12/2023	10:11	PR Newswire (US)	Study published in Antiviral Research supports promise of Scinai Immunotherapeutics' coronavirus NanoAb as aerosolized prophylactic and therapeutic drug	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
29/11/2023	11:25	PR Newswire (US)	European Investment Bank (EIB) extends maturity of its finance facility with Scinai Immunotherapeutics from 2027 to 2031	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
20/11/2023	09:30	PR Newswire (US)	Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity Rule	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
06/11/2023	09:30	GlobeNewswire Inc.	Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
03/11/2023	17:30	GlobeNewswire Inc.	Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
31/10/2023	10:00	GlobeNewswire Inc.	European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd